$711.68
1.860.26%
al cierre: -
$710.15
-1.53-0.22%
After hour: Aug 22, 7:57 PM EDT
Eli Lilly emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
08/07/2025 | LLY | Eli Lilly | FY | 2025 | $21.75 | $23.00 | $21.59 | $60.00B | $62.00B | $59.45B | |
05/01/2025 | LLY | Eli Lilly | FY | 2025 | $20.78 | $22.28 | $21.59 | $58.00B | $61.00B | $59.45B | |
02/06/2025 | LLY | Eli Lilly | FY | 2025 | $22.50 | $24.00 | $21.59 | $58.00B | $61.00B | $59.45B | |
01/14/2025 | LLY | Eli Lilly | FY | 2025 | — | — | — | $58.00B | $61.00B | $59.45B | |
01/14/2025 | LLY | Eli Lilly | FY | 2024 | — | — | — | $45.00B | $45.00B | $45.16B | |
01/14/2025 | LLY | Eli Lilly | Q4 | 2024 | — | — | — | $13.50B | $13.50B | $13.57B | |
10/30/2024 | LLY | Eli Lilly | FY | 2024 | $13.02 | $13.52 | $12.66 | $45.40B | $46.00B | $45.16B | |
08/08/2024 | LLY | Eli Lilly | FY | 2024 | $16.10 | $16.60 | $12.66 | $45.40B | $46.60B | $45.16B | |
04/30/2024 | LLY | Eli Lilly and Co | FY | 2024 | $13.50 | $14.00 | $12.66 | $42.40B | $43.60B | $45.16B | |
02/06/2024 | LLY | Eli Lilly | FY | 2024 | $12.20 | $12.70 | $12.43 | $40.40B | $41.60B | $39.38B | |
11/02/2023 | LLY | Eli Lilly | FY | 2023 | $6.50 | $6.70 | $6.72 | $33.40B | $33.90B | $33.52B | |
08/08/2023 | LLY | Eli Lilly | FY | 2023 | $9.70 | $9.90 | $8.71 | $33.40B | $33.90B | $31.44B | |
04/27/2023 | LLY | Eli Lilly | FY | 2023 | $8.65 | $8.85 | $8.45 | $31.20B | $31.70B | $30.64B | |
02/02/2023 | LLY | Eli Lilly | FY | 2023 | $8.35 | $8.55 | $8.28 | $30.30B | $30.80B | $30.55B | |
01/19/2023 | LLY | Eli Lilly | FY | 2023 | $8.10 | $8.30 | $8.27 | $30.30B | $30.80B | $30.48B | |
12/13/2022 | LLY | Eli Lilly | FY | 2022 | $7.70 | $7.85 | $7.78 | $28.50B | $29.00B | $28.62B | |
12/13/2022 | LLY | Eli Lilly | FY | 2023 | $8.10 | $8.30 | $9.15 | $30.30B | $30.80B | $30.12B | |
11/01/2022 | LLY | Eli Lilly | FY | 2022 | $7.70 | $7.85 | $7.99 | $28.50B | $29.00B | $28.85B | |
08/04/2022 | LLY | Eli Lilly | FY | 2022 | $7.90 | $8.05 | $8.08 | $28.80B | $29.30B | $28.27B | |
04/28/2022 | LLY | Eli Lilly | FY | 2022 | $8.15 | $8.30 | $8.19 | $28.80B | $29.30B | $26.80B | |
02/03/2022 | LLY | Eli Lilly | FY | 2022 | $8.50 | $8.65 | $7.54 | $27.80B | $28.30B | $24.88B | |
12/15/2021 | LLY | Eli Lilly | FY | 2022 | $8.50 | $8.65 | $7.30 | $27.80B | $28.30B | $24.73B | |
12/15/2021 | LLY | Eli Lilly | FY | 2021 | $8.15 | $8.20 | $7.13 | $28.00B | $28.30B | $24.57B | |
10/26/2021 | LLY | Eli Lilly | FY | 2021 | $7.95 | $8.05 | $6.80 | $27.20B | $27.60B | $23.52B | |
08/03/2021 | LLY | Eli Lilly | FY | 2021 | $7.80 | $8.00 | $7.90 | $26.80B | $27.40B | $27.22B | |
04/27/2021 | LLY | Eli Lilly | FY | 2021 | $7.80 | $8.00 | $8.23 | $26.60B | $27.60B | $27.69B | |
01/29/2021 | LLY | Eli Lilly | FY | 2021 | $7.75 | $8.40 | $8.20 | $26.50B | $28.00B | $27.59B | |
12/15/2020 | LLY | Eli Lilly | FY | 2021 | $7.75 | $8.40 | $8.07 | $26.50B | $28.00B | $26.47B | |
12/15/2020 | LLY | Eli Lilly | FY | 2020 | $7.45 | $7.65 | $7.32 | $24.20B | $24.70B | $23.93B |
La orientación más reciente para Eli Lilly (LLY) se informó el agosto 7, 2025 para el año completo 2025. La empresa proporcionó una guía de ganancias por acción en el rango de $21.75 a $23.00, en comparación con el EPS estimado de $21.59. Además, Eli Lilly pronosticó ingresos entre $60.00B y $62.00B para el trimestre.
Explora orientación y previsión sobre todos los valores.